PSPC1 Inhibition Synergizes with Poly(ADP-ribose) Polymerase Inhibitors in a Preclinical Model of BRCA-Mutated Breast/Ovarian Cancer

PSPC1 Inhibition Synergizes with Poly(ADP-ribose) Polymerase Inhibitors in a Preclinical Model of BRCA-Mutated Breast/Ovarian Cancer

Poly (ADP-ribose) polymerase (PARP) inhibitors are effective against <i>BRCA1/2</i>-mutated cancers through synthetic lethality. Unfortunately, most cases ultimately develop acquired resistance. Therefore, enhancing PARP inhibitor sensitivity and preventing resistance in those cells are...

Full description

Bibliographic Details
Main Authors: Mithun Ghosh, Min Sil Kang, Nar Bahadur Katuwal, Sa Deok Hong, Yeong Gyu Jeong, Seong Min Park, Seul-Gi Kim, Yong Wha Moon
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:International Journal of Molecular Sciences
Subjects:
PARP inhibitor
<i>PSPC1</i>
DNA double-strand break
sensitivity
Online Access:https://www.mdpi.com/1422-0067/24/23/17086

Internet

https://www.mdpi.com/1422-0067/24/23/17086

Similar Items